324 related articles for article (PubMed ID: 16205605)
21. [Progress in the treatment of osteoporosis].
Sugimoto T
Rinsho Byori; 2008 Oct; 56(10):887-93. PubMed ID: 19068785
[TBL] [Abstract][Full Text] [Related]
22. Emerging concepts in osteoporosis and bone strength.
Rubin CD
Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
[TBL] [Abstract][Full Text] [Related]
23. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation.
Czerwiński E; Badurski JE; Marcinowska-Suchowierska E; Osieleniec J
Ortop Traumatol Rehabil; 2007; 9(4):337-56. PubMed ID: 17882114
[TBL] [Abstract][Full Text] [Related]
24. [Management of glucocorticoid-induced osteoporosis in childhood].
Tanaka H
Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density correlation with fractures in nonambulatory pediatric patients.
Khoury DJ; Szalay EA
J Pediatr Orthop; 2007; 27(5):562-6. PubMed ID: 17585268
[TBL] [Abstract][Full Text] [Related]
26. Premenopausal osteoporosis.
Bischoff L; Derk CT
Minerva Med; 2008 Feb; 99(1):55-63. PubMed ID: 18299696
[TBL] [Abstract][Full Text] [Related]
27. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
Soen S
Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
[TBL] [Abstract][Full Text] [Related]
28. The role of dual energy x-ray absorptiometry in aiding the diagnosis of pediatric osteogenesis imperfecta.
Moore MS; Minch CM; Kruse RW; Harcke HT; Jacobson L; Taylor A
Am J Orthop (Belle Mead NJ); 1998 Dec; 27(12):797-801. PubMed ID: 9880097
[TBL] [Abstract][Full Text] [Related]
29. [Osteoporosis in children].
Lorenc RS; Olszaniecka M
Przegl Lek; 2000; 57(2):127-30. PubMed ID: 10907357
[TBL] [Abstract][Full Text] [Related]
30. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
31. Treatment options for thalassemia patients with osteoporosis.
Terpos E; Voskaridou E
Ann N Y Acad Sci; 2010 Aug; 1202():237-43. PubMed ID: 20712799
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of osteoporosis treatment efficacy by bone mass measurement].
Miki T; Tomiyoshi Y
Clin Calcium; 2004 Dec; 14(12):19-26. PubMed ID: 15577169
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
34. The prevention and treatment of osteoporosis: a review.
Cosman F
MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
[TBL] [Abstract][Full Text] [Related]
35. Clinical management of childhood osteoporosis.
Chan YY; Bishop NJ
Int J Clin Pract; 2002 May; 56(4):280-6. PubMed ID: 12074211
[TBL] [Abstract][Full Text] [Related]
36. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
37. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
Yamauchi M
Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
[TBL] [Abstract][Full Text] [Related]
38. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
Takayanagi R
Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
[TBL] [Abstract][Full Text] [Related]
39. [Osteoporosis in developmental age: diagnostic and therapeutic problems].
Chlebna-Sokół D
Pol Merkur Lekarski; 1998 Oct; 5(28):229-32. PubMed ID: 10101450
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of osteoporosis.
Lash RW; Nicholson JM; Velez L; Van Harrison R; McCort J
Prim Care; 2009 Mar; 36(1):181-98, x. PubMed ID: 19231609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
